- Home
- EW vs RGC Comparison
EW vs RGC Comparison
Compare EW & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EW
- RGC
- Stock Information
- Founded
- EW 1958
- RGC 2014
- Country
- EW United States
- RGC Hong Kong
- Employees
- EW N/A
- RGC N/A
- Industry
- EW Industrial Specialties
- RGC Medicinal Chemicals and Botanical Products
- Sector
- EW Health Care
- RGC Health Care
- Exchange
- EW Nasdaq
- RGC Nasdaq
- Market Cap
- EW 44.8B
- RGC 38.6B
- IPO Year
- EW 2000
- RGC 2021
- Fundamental
- Price
- EW $78.10
- RGC $14.66
- Analyst Decision
- EW Buy
- RGC
- Analyst Count
- EW 20
- RGC 0
- Target Price
- EW $80.40
- RGC N/A
- AVG Volume (30 Days)
- EW 3.5M
- RGC 2.8M
- Earning Date
- EW 07-24-2025
- RGC 06-30-2025
- Dividend Yield
- EW N/A
- RGC N/A
- EPS Growth
- EW 200.69
- RGC N/A
- EPS
- EW 7.02
- RGC N/A
- Revenue
- EW $5,522,300,000.00
- RGC N/A
- Revenue This Year
- EW $11.81
- RGC N/A
- Revenue Next Year
- EW $9.54
- RGC N/A
- P/E Ratio
- EW $11.11
- RGC N/A
- Revenue Growth
- EW 8.23
- RGC N/A
- 52 Week Low
- EW $58.93
- RGC $0.08
- 52 Week High
- EW $95.25
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- EW 58.61
- RGC 45.32
- Support Level
- EW $75.84
- RGC $9.39
- Resistance Level
- EW $78.90
- RGC $30.00
- Average True Range (ATR)
- EW 1.48
- RGC 6.44
- MACD
- EW 0.15
- RGC -1.70
- Stochastic Oscillator
- EW 85.51
- RGC 20.68
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.